Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial

INTRODUCTION: Crohn’s disease (CD) is a chronic inflammatory bowel disease with a heterogeneous clinical presentation, relapse rate and treatment response. At present, no markers are available to adequately predict disease course at diagnosis. To prevent overtreatment of patients with a relative mil...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ Open
Hlavní autoři: Janssen, Laura, Romberg-Camps, Mariëlle, van Bodegraven, Ad, Haans, Jeoffrey, Aquarius, Michèl, Boekema, Paul, Munnecom, Tamara, Brandts, Lloyd, Joore, Manuela, Masclee, Adrian, Jonkers, D, Pierik, M
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2021
Témata:
Gastroenterology and Hepatology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8098960/
https://ncbi.nlm.nih.gov/pubmed/33947729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-042885
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky